Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

AstraZeneca
Farmers Insurance
Merck
UBS
Baxter
Accenture
Healthtrust
QuintilesIMS
Argus Health

Generated: December 13, 2018

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR TAZAROTENE

« Back to Dashboard

Clinical Trials for Tazarotene

Trial ID Title Status Sponsor Phase Summary
NCT00145106 Comparison of Tazarotene and Minocycline Therapies for Maintenance of Facial Acne Vulgaris Completed Allergan Phase 4 The purpose of the study is to compare the efficacy of three maintenance regimens (topical tazarotene, oral minocycline, or both) in sustaining improvement in acne.
NCT00145106 Comparison of Tazarotene and Minocycline Therapies for Maintenance of Facial Acne Vulgaris Completed Jefferson Medical College of Thomas Jefferson University Phase 4 The purpose of the study is to compare the efficacy of three maintenance regimens (topical tazarotene, oral minocycline, or both) in sustaining improvement in acne.
NCT00145106 Comparison of Tazarotene and Minocycline Therapies for Maintenance of Facial Acne Vulgaris Completed Milton S. Hershey Medical Center Phase 4 The purpose of the study is to compare the efficacy of three maintenance regimens (topical tazarotene, oral minocycline, or both) in sustaining improvement in acne.
NCT00145106 Comparison of Tazarotene and Minocycline Therapies for Maintenance of Facial Acne Vulgaris Completed New York University School of Medicine Phase 4 The purpose of the study is to compare the efficacy of three maintenance regimens (topical tazarotene, oral minocycline, or both) in sustaining improvement in acne.
NCT00145106 Comparison of Tazarotene and Minocycline Therapies for Maintenance of Facial Acne Vulgaris Completed State University of New York - Downstate Medical Center Phase 4 The purpose of the study is to compare the efficacy of three maintenance regimens (topical tazarotene, oral minocycline, or both) in sustaining improvement in acne.
NCT00145106 Comparison of Tazarotene and Minocycline Therapies for Maintenance of Facial Acne Vulgaris Completed KGL, Inc. Phase 4 The purpose of the study is to compare the efficacy of three maintenance regimens (topical tazarotene, oral minocycline, or both) in sustaining improvement in acne.
Trial ID Title Status Sponsor Phase Summary

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Clinical Trial Conditions for Tazarotene

Condition Name

Condition Name for Tazarotene
Intervention Trials
Acne Vulgaris 20
Plaque Psoriasis 4
Nail Psoriasis 2
Hand-foot Skin Reaction 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Tazarotene
Intervention Trials
Acne Vulgaris 20
Psoriasis 8
Basal Cell Nevus Syndrome 2
Darier Disease 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Tazarotene

Trials by Country

Trials by Country for Tazarotene
Location Trials
United States 112
Canada 6
India 2
Belize 1
Germany 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Tazarotene
Location Trials
California 11
Florida 10
Texas 8
Pennsylvania 8
New York 6
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Tazarotene

Clinical Trial Phase

Clinical Trial Phase for Tazarotene
Clinical Trial Phase Trials
Phase 4 8
Phase 3 8
Phase 2 10
[disabled in preview] 12
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Tazarotene
Clinical Trial Phase Trials
Completed 24
Recruiting 5
Terminated 3
[disabled in preview] 5
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Tazarotene

Sponsor Name

Sponsor Name for Tazarotene
Sponsor Trials
Stiefel, a GSK Company 8
GlaxoSmithKline 8
Allergan 4
[disabled in preview] 6
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Tazarotene
Sponsor Trials
Industry 38
Other 19
NIH 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Argus Health
Citi
Johnson and Johnson
Accenture
UBS
McKesson
McKinsey
Chubb
Federal Trade Commission

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.